The expansion of the white-tailed deer population, wildlife habitat encroachment and greater awareness of the disease by physicians and the public have all contributed to the increasing numbers of Babesiosis.
3 Clinical manifestations can vary from asymptomatic to life-threatening disease. In pregnancy, babesiosis can imitate HELLP (hemolysis, elevated liver enzymes, low platelets) syndrome. 4, 5 A high index of suspicion is needed to appropriately diagnose and treat HELLP imitators, such as Babesiosis, in pregnancy.
Transmission Tick-borne
Although adult ticks can transmit B. microti, most cases are result from exposure to I. scapularis nymphs (►Fig. 1) during late spring through summer. 3 Tick-borne transmission of Babesia primarily peaks during warm months and has been on the rise in the last decade, becoming almost as common as Lyme disease in some areas of southern New England.
2,3
Symptoms usually occur 1 to 4 weeks after an infected tick bite, 3 although many patients infected with babesiosis cannot recall a tick bite.
2

Blood Transfusion
Babesiosis is currently the most common red blood cell (RBC) transfusion-transmitted pathogen reported to the U.S. Food and Drug Administration (FDA). 6 Transfusion-transmitted babesiosis has been linked various blood products including RBCs, frozen deglycerolized RBCs, and whole blood-derived platelet concentrates (presumably from residual RBCs). 6 This method of transmission may be one explanation for cases to occur in nonendemic areas because (1) patients with subclinical infection may donate blood in nonendemic areas and (2) infected blood may be exported to nonendemic areas in times of shortages. 3, 6, 7 Patients with transfusion of contaminated blood products usually become symptomatic 1 to 9 weeks after transfusion with a median incubation period of 34 days.
3,6
In a highly endemic area, some blood collection agencies have implemented investigational testing protocols for blood donor testing which helped in removing infected units from blood supply. Asymptomatic and mild infections usually occur in patients who are immunocompetent and have parasitemia < 4%.
1
Symptoms of mild/moderate disease are similar to common viral illnesses with gradual onset of malaise and fatigue.
1,11
Fever usually develops with temperatures as high as 105.6°F.
Other common symptoms include chills and sweats and may be accompanied by a headache, myalgia, anorexia, nonproductive cough, arthralgias, and nausea.
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Patients affected with severe infection often have nausea, vomiting, diarrhea, and hemoglobinuria. 7 Severe derangements in laboratory values can lead to a variety of complications and require hospitalization. Also, a parasitemia level > 4% is associated with severe disease. Risk factors associated with severe disease are parasitemia > 4%, neonates, age of 50 years old and immunocompromised persons, such as those with cancer, human immunodeficiency virus infection, hemoglobinopathy, functional asplenia, chronic heart, lung, or liver disease. 3 Pregnancy may predispose to increased severity of disease since it is an immunocompromised state; however, maternal risk factors for severe babesiosis are not well understood. 4, 13 However, it is important to note that there is not a strict relationship between the level of parasitemia above 4% and the severity of illness.
12
In both mild and severe disease, fever is the most common sign of babesiosis infection and maybe occasionally accompanied by splenomegaly or hepatomegaly.
3,11 Although less common, mild pharyngeal erythema, jaundice, retinopathy, and retinal infarcts are also sometimes present. 3 A rash is not usually present; however, if noted should raise the concern for coinfection with Lyme disease. 3, 11 Physicians should keep babesiosis on their list of differentials for febrile transfusion reaction, especially for the elderly, immunocompromised, and patients who have undergone a splenectomy.
7
Complications
About 50% of patients hospitalized with babesiosis develop complications. 11 The most common complications are acute respiratory distress syndrome and disseminated intravascular coagulation. 11, 14 Other complications, such as congestive heart failure, coma, liver failure, renal failure or splenic rupture, may also occur.
11 Fatality rates are 6 to 9% amongst hospitalized patients and up to 21% in those patients with immunosuppression.
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When comparing nonpregnant patients with complications, severe anemia defined as a hemoglobin level 10 g/dL, were associated with complicated babesiosis.
14 Parasitemia level > 10% was associated with complicated babesiosis but the association did not reach statistical significance. About 1% of patients infected with babesiosis have coinfection with another tick-borne disease, including anaplasmosis, ehrlichiosis, and Lyme disease. 4 Thus, it is important to test for other tick-borne agents when presented with a presumed tick-borne disease.
7
Laboratory Abnormalities
Laboratory findings from the invasion and destruction of RBCs can lead to hemolytic anemia and can render laboratory abnormalities including low hemoglobin, low hematocrit, and elevated lactate dehydrogenase. Serum liver enzyme concentrations are often elevated, and thrombocytopenia is common. Severe illness may cause elevated serum levels of blood urea nitrogen and creatinine and are often accompanied by proteinuria.
3
The laboratory findings of babesiosis are similar to HELLP syndrome and can often lead to a diagnostic dilemma. 4 The clinical course of HELLP syndrome, like babesiosis, is often characterized by progressive and sometimes with a sudden deterioration. Thus, management of patients with preeclampsia or HELLP syndrome with worsening laboratory findings includes prompt delivery if beyond 34 weeks of gestation or earlier if there is disseminated intravascular coagulation, liver infarction, hemorrhage, renal failure, pulmonary edema, placental abruption, or nonreassuring fetal status.
16
The differential diagnosis of babesiosis should be considered on the differential of HELLP syndrome imitators to avoid iatrogenic preterm delivery, delay in treatment, and complications of undiagnosed and untreated babesiosis.
17 ►Table 1
demonstrates the similar clinical manifestations and laboratory evaluation in HELLP syndrome and babesiosis. A peripheral blood smear, which is typically done to evaluate for hemolysis in patients with HELLP syndrome, may aid in the diagnostic process by detecting intraerythrocytic parasites. 5 
Babesiosis in Pregnancy: Case Series
In a review of the literature and our institution's experience with babesiosis, we identified eight cases in pregnancy found in ►Table 2. Two of these patients never had a fever.
5,17 HELLP syndrome was considered in 50% of the cases. All patients had laboratory features found in HELLP syndrome, including transaminitis (not reported by Raucher et al); and thrombocytopenia ranging from 8,000-120,000/μL. One patient had proteinuria (case 2). Two patients had coinfection with other tick-borne diseases, namely Lyme disease (case 2) and anaplasmosis.
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Our review in pregnancy reinforced that parasitemia load does not necessarily correlate with severity of illness. One patient that had acute hypoxemic respiratory failure had a parasitemia load of just 1.1% (case 1). Laboratory abnormalities and symptomatic infection were present in a patient with a parasitemia load of just 0.08% (case 2). One patient with a parasitemia load of 19.13% developed severe disseminated intravascular coagulation (DIC), acute kidney infection (AKI), and complications of hemorrhage secondary to DIC (case 3).
Seventy-five percent of the patients were treated with the preferred first line treatment, clindamycin, and quinine. One patient (case 1) had a drug reaction to the regimen; hence, azithromycin and atavoquone were used in her case. Raucher, et al did not utilize antiparasitic agents. One patient with severe babesiosis and parasitemia of 19.13% required treatment with plasma exchange in addition to antibiotics (case 3). Two cases required blood transfusion for anemia. Case 1 was lost to follow-up, and all other pregnancies were delivered at term. There was one case of vertical transmission of babesiosis in this series.
Treatment Antimicrobial Therapy
Per CDC guidelines, the standard antibiotic treatment regimen for nonsevere babesiosis in adults is azithromycin plus atovaquone. Clindamycin and quinine is the preferred regimen in pregnant patients and severely ill patients. Drug regimens for both groups are for approximately 7 to 10 days. Clindamycin and quinine provide better placental penetration to prevent vertical transmission; however, atovaquone and azithromycin have also been used to treat malaria in pregnancy without increased risk of congenital birth defects, stillbirth, or anemia. 4, 17 An alternative drug therapy option is critical to note because quinine therapy is often interrupted because of drug toxicity; thus, azithromycin plus atovaquone may be considered appropriate for some hospitalized patients with severe babesiosis. 14 Antibiotic dosing and side effects are noted in ►Table 3. Persistent or relapsing babesiosis infections may be present in profoundly immunocompromised patients, and treatment can be extended for 6 weeks or longer. Negative blood smears are obtained for 2 weeks or longer before discontinuation.
15
Current guidelines only advocate treating symptomatic babesiosis patients. 15 There are no randomized trials or studies to guide the treatment in pregnancy. However, persons with underlying health conditions may have a significant mortality risk with exposure to babesial infection.
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As pregnant women are often considered immunocompromised, and evidence also exists in the literature regarding transplacental infection and congenital babesiosis, we would advocate for the treatment of all pregnant women diagnosed with babesiosis, even if asymptomatic. The pediatric team should also be alerted to maternal history of babesiosis so that appropriate blood work and surveillance can be performed after delivery.
Exchange Transfusion
Exchange transfusion has been recommended by the Infectious Disease Society of America and American Society for Apheresis for patients with high-grade parasitemia > 10% or in the presence of significant comorbidities including hemolysis, renal, hepatic, or pulmonary compromise. 12 Exchange transfusion is used in conjunction with antimicrobial agents. 18 Patients generally tolerate the exchange transfusion well with exposure to multiple red cell transfusions being the most significant risk. 12 The exchange transfusion is believed to have multiple beneficial effects including removing proinflammatory cytokines and reducing the level of parasitemia. 12 Because the severity of disease is not always directly related to parasite load, some have suggested consideration for RBC exchange at lower parasite loads, especially in immunocompromised hosts. 18 There are no data available to determine if partial exchange is preferable to whole blood exchange. Expert consultation with a hematologist and infectious disease experts should be obtained.
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Take Home Points
Babesiosis is a rare tick-borne illness which can be a parasitic imitator of HELLP syndrome. Clinical manifestations and laboratory evaluation may be similar between the two conditions making it difficult to sometimes distinguish between them. Babesiosis should be considered on the differential for patients who live or have traveled to endemic areas of babesiosis or have received a blood transfusion. A blood smear with the presence of intraerythrocytic parasites may help to guide diagnosis in patients with hemolytic anemia. 4 A high index of suspicion is essential to ensure prompt and correct treatment of babesiosis and to avoid iatrogenic preterm delivery potentially. 
